Benzodiazepines Remain Important Therapeutic Options in Psychiatric Practice
The DOI matches its Crossref record; 105 of the 105 references it cites were found in a registry or an index.
Abstract
Benzodiazepines and medications acting on benzodiazepine receptors that do not have a benzodiazepine structure (z-drugs) have been viewed by some experts and regulatory bodies as having limited benefit and significant risks. Data presented in this article support the use of these medications as treatments of choice for acute situational anxiety, chronic anxiety disorders, insomnia, alcohol withdrawal syndromes, and catatonia. They may also be useful adjuncts in the treatment of anxious depression and mania, and for medically ill patients. Tolerance develops to sedation and possibly psychomotor impairment, but not to the anxiolytic effect of benzodiazepines. Sedation can impair cognitive function in some patients, but assertions that benzodiazepines increase the risk of dementia are not supported by recent data. Contrary to popular opinion, benzodiazepines are not frequently misused or conduits to misuse of other substances in patients without substance use disorders who are prescribed these medications for appropriate indications; most benzodiazepine misuse involves medications that are obtained from other people. Benzodiazepines are usually not lethal in overdose except when ingested with other substances, especially alcohol and opioids. Benzodiazepines comprise one of the few classes of psychotropic medication the mechanisms of action of which are clearly delineated, allowing for greater precision in their clinical use. These medications, therefore, belong in the therapeutic armamentarium of the knowledgeable clinician.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“After several decades of use, Benzodiazepines and Benzodiazepine Receptor Agonists remain important therapeutic options for the treatment of mental health related concerns such as anxiety and sleep disorders.1”
Citations
Cites
Sateia, M. J., Buysse, D. J., Krystal, A. D., Neubauer, D. N., & Heald, J. L. (2017) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.6470 · Cited by 1,519
Penninx, B. W., Pine, D. S., Holmes, E. A., & Reif, A. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00359-7 · Cited by 740
Tromp, A. M., Pluijm, S. M. F., Smit, J. H., Deeg, D. J. H., Bouter, L. M., & Lips, P. (2001) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(01)00349-3 · Cited by 666
Drug–drug interaction between clobazam and cannabidiol in children with refractory epilepsy
Geffrey, A. L., Pollack, S. F., Bruno, P. L., & Thiele, E. A. (2015) · Epilepsia · doi:10.1111/epi.13060 · Cited by 496
Slee, A., Nazareth, I., Bondaronek, P., Liu, Y., Cheng, Z., & Freemantle, N. (2019) · The Lancet · doi:10.1016/s0140-6736(18)31793-8 · Cited by 372
Withdrawal Reaction after Long-Term Therapeutic Use of Benzodiazepines
Busto, U., Sellers, E. M., Naranjo, C. A., Cappell, H., Sanchez-Craig, M., & Sykora, K. (1986) · New England Journal of Medicine · doi:10.1056/nejm198610023151403 · Cited by 369
Dolovich, L. R., Addis, A., Vaillancourt, J. M. R., Power, J. D. B., Koren, G., & Einarson, T. R. (1998) · BMJ · doi:10.1136/bmj.317.7162.839 · Cited by 353
The Pharmacologic Treatment of Anxiety Disorders: A Review of Progress
Ravindran, L. N., & Stein, M. B. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.10r06218blu · Cited by 317
Paradoxical reactions to benzodiazepines: literature review and treatment options
Mancuso, C. E., Tanzi, M. G., & Gabay, M. (2004) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.24.13.1177.38089 · Cited by 298
Acute and Persistent Withdrawal Syndromes Following Discontinuation of Psychotropic Medications
Cosci, F., & Chouinard, G. (2020) · Psychotherapy and Psychosomatics · doi:10.1159/000506868 · Cited by 265
Dassanayake, T., Michie, P., Carter, G., & Jones, A. (2011) · Drug Safety · doi:10.2165/11539050-000000000-00000 · Cited by 253
Wikner, B. N., Stiller, C., Bergman, U., Asker, C., & Källén, B. (2007) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1457 · Cited by 253
Benzodiazepines for alcohol withdrawal
Amato, L., Minozzi, S., Vecchi, S., & Davoli, M. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005063.pub3 · Cited by 245
Lonergan, E., Luxenberg, J., & Areosa Sastre, A. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006379.pub3 · Cited by 223
Alcohol or Benzodiazepine Co-involvement With Opioid Overdose Deaths in the United States, 1999-2017
Tori, M. E., Larochelle, M. R., & Naimi, T. S. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.2361 · Cited by 188
Lorazepam for chronic catatonia: a randomized, double-blind, placebo-controlled cross-over study
Ungvari, G. S., Chiu, H. F. K., Chow, L. Y., Lau, B. S. T., & Tang, W. K. (1999) · Psychopharmacology · doi:10.1007/s002130050904 · Cited by 182
Benzodiazepines and Injurious Falls in Community Dwelling Elders
Pariente, A., Dartigues, J.-F., Benichou, J., Letenneur, L., Moore, N., & Fourrier-Réglat, A. (2008) · Drugs & Aging · doi:10.2165/00002512-200825010-00007 · Cited by 172
Benzodiazepines for schizophrenia
Dold, M., Li, C., Tardy, M., Khorsand, V., Gillies, D., & Leucht, S. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006391.pub2 · Cited by 169
Offidani, E., Guidi, J., Tomba, E., & Fava, G. A. (2013) · Psychotherapy and Psychosomatics · doi:10.1159/000353198 · Cited by 166
Antidepressants plus benzodiazepines for major depression
Furukawa, T. A., Streiner, D., Young, L. T., & Kinoshita, Y. (2001) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001026 · Cited by 161
Alternative treatment strategies for catatonia: A systematic review
Beach, S. R., Gomez-Bernal, F., Huffman, J. C., & Fricchione, G. L. (2017) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2017.06.011 · Cited by 149
Greenblatt, D. J., & Shader, R. I. (1974) · New England Journal of Medicine · doi:10.1056/nejm197411072911906 · Cited by 138
Gomez, A. F., Barthel, A. L., & Hofmann, S. G. (2018) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2018.1472767 · Cited by 125
Effects of benzodiazepines on psychomotor performance.
Wittenborn, Jr. (1979) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1979.tb04667.x · Cited by 124
Motherisk Rounds: The Fetal Safety of Benzodiazepines: An Updated Meta-analysis
Enato, E. F. O., Moretti, M. E., & Koren, G. (2011) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/s1701-2163(16)34772-7 · Cited by 123
Catatonia is Hidden in Plain Sight Among Different Pediatric Disorders: A Review Article
Dhossche, D. M., & Wachtel, L. E. (2010) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2010.07.001 · Cited by 120
(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.2.162 · Cited by 111
Liu, S., O’Donnell, J., Gladden, R. M., McGlone, L., & Chowdhury, F. (2021) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm7034a2 · Cited by 109
Effect of oral contraceptives on triazolam, temazepam, alprazolam, and lorazepam kinetics
Stoehr, G. P., Kroboth, P. D., Juhl, R. P., Wender, D. B., Phillips, J. P., & Smith, R. B. (1984) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1984.240 · Cited by 103
Comparative Tolerability of Newer Agents for Insomnia
Zammit, G. (2009) · Drug Safety · doi:10.2165/11312920-000000000-00000 · Cited by 98
Balancing the Risks and Benefits of Benzodiazepines
Hirschtritt, M. E., Olfson, M., & Kroenke, K. (2021) · JAMA · doi:10.1001/jama.2020.22106 · Cited by 96
Otto, M. W., McHugh, R. K., Simon, N. M., Farach, F. J., Worthington, J. J., & Pollack, M. H. (2010) · Behaviour Research and Therapy · doi:10.1016/j.brat.2010.04.002 · Cited by 95
Pharmacological Advances in the Treatment of Insomnia
M. Richey, S., & D. Krystal, A. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211796197052 · Cited by 93
Catatonia in autism: implications across the life span
Kakooza‐Mwesige, A., Wachtel, L. E., & Dhossche, D. M. (2008) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-008-0676-x · Cited by 93
Benzodiazepine Use and Neuropsychiatric Outcomes in the ICU: A Systematic Review*
Kok, L., Slooter, A. J., Hillegers, M. H., van Dijk, D., & Veldhuijzen, D. S. (2018) · Critical Care Medicine · doi:10.1097/ccm.0000000000003300 · Cited by 87
Pharmacological treatment for generalized anxiety disorder in adults: an update
Reinhold, J. A., & Rickels, K. (2015) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2015.1059424 · Cited by 82
Emergency pharmacotherapy of delirium in the critically ill cancer patient
Adams, F., Fernandez, F., & Andersson, B. S. (1986) · Psychosomatics · doi:10.1016/s0033-3182(86)72737-0 · Cited by 82
Benzodiazepines as a monotherapy in depressive disorders: a systematic review
Benasi, G., Guidi, J., Offidani, E., Balon, R., Rickels, K., & Fava, G. A. (2018) · Psychotherapy and Psychosomatics · doi:10.1159/000486696 · Cited by 79
Phenobarbital Technique for Treatment of Barbiturate Dependence
Smith, D. E. (1971) · Archives of General Psychiatry · doi:10.1001/archpsyc.1971.01750070058007 · Cited by 78
Park, T. W., Larochelle, M. R., Saitz, R., Wang, N., Bernson, D., & Walley, A. Y. (2020) · Addiction · doi:10.1111/add.14886 · Cited by 78
Panic Disorder: Long-Term Pharmacotherapy and Discontinuation
Rickels, K., & Schweizer, E. (1998) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199812001-00004 · Cited by 77
Dold, M., Li, C., Gillies, D. M., & Leucht, S. (2013) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2013.03.001 · Cited by 76
Chronic benzodiazepine administration
Miller, L. G., Woolverton, S., Greenblatt, D. J., Lopez, F. A., Roy, R. B., & Shader, R. I. (1989) · Biochemical Pharmacology · doi:10.1016/0006-2952(89)90584-4 · Cited by 75
Posternak, M. A., & Mueller, T. I. (2001) · The American Journal on Addictions · doi:10.1080/105504901750160484 · Cited by 74
Benzodiazepines for neuroleptic-induced acute akathisia
Resende Lima, A., Soares-Weiser, K., Bacaltchuk, J., & Barnes, T. R. (1999) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001950 · Cited by 72
Greenblatt, D. J., & Shader, R. I. (1974) · New England Journal of Medicine · doi:10.1056/nejm197412052912308 · Cited by 71
Osler, M., & Jørgensen, M. B. (2020) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2019.19030315 · Cited by 71
The role of benzodiazepines in elderly suicides
Carlsten, A., Waern, M., Holmgren, P., & Allebeck, P. (2003) · Scandinavian Journal of Public Health · doi:10.1080/14034940210167966 · Cited by 70
Wilkinson, G., Balestrieri, M., Ruggeri, M., & Bellantuono, C. (1991) · Psychological Medicine · doi:10.1017/s0033291700029986 · Cited by 63
When Anxiety and Depression Coexist: The Role of Differential Diagnosis Using Clinimetric Criteria
Cosci, F., & Fava, G. A. (2021) · Psychotherapy and Psychosomatics · doi:10.1159/000517518 · Cited by 63
Lupattelli, A., Chambers, C., Bandoli, G., Handal, M., Skurtveit, S. O., & Nordeng, H. (2019) · JAMA Network Open · doi:10.1001/jamanetworkopen.2019.1435 · Cited by 61
Association between benzodiazepines and suicide risk: a matched case-control study
Cato, V., Holländare, F., Nordenskjöld, A., & Sellin, T. (2019) · BMC Psychiatry · doi:10.1186/s12888-019-2312-3 · Cited by 60
Movement disorders in catatonia
Wijemanne, S., & Jankovic, J. J. (2014) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2014-309098 · Cited by 59
Kleykamp, B. A., Griffiths, R. R., McCann, U. D., Smith, M. T., & Mintzer, M. Z. (2011) · Experimental and Clinical Psychopharmacology · doi:10.1037/a0025237 · Cited by 56
Prescription Drugs Used in Insomnia
Dujardin, S., Pijpers, A., & Pevernagie, D. (2020) · Sleep Medicine Clinics · doi:10.1016/j.jsmc.2020.02.002 · Cited by 56
Chen, T.-R., Huang, H.-C., Hsu, J.-H., Ouyang, W.-C., & Lin, K.-C. (2019) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2019.08.014 · Cited by 54
Treating Nonspecific Anxiety and Anxiety Disorders in Patients With Bipolar Disorder: A Review
Rakofsky, J. J., & Dunlop, B. W. (2011) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.09r05815gre · Cited by 52
Huitfeldt, A., Sundbakk, L. M., Skurtveit, S. O., Handal, M., & Nordeng, H. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.5860 · Cited by 52
Coprescription of Opioids With Other Medications and Risk of Opioid Overdose
Khan, N. F., Bykov, K., Glynn, R. J., Barnett, M. L., & Gagne, J. J. (2021) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.2314 · Cited by 48
Chang, C., Wu, C., Huang, Y.-W., Chau, Y., & Tsai, H. (2015) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000440 · Cited by 46
Harbourt, K., Nevo, O. N., Zhang, R., Chan, V., & Croteau, D. (2020) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.5004 · Cited by 46
Shinfuku, M., Kishimoto, T., Uchida, H., Suzuki, T., Mimura, M., & Kikuchi, T. (2019) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000276 · Cited by 45
Clinical predictors of response to treatment in catatonia
Narayanaswamy, J. C., Tibrewal, P., Zutshi, A., Srinivasaraju, R., & Math, S. B. (2012) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2012.01.011 · Cited by 44
Gaining insight into benzodiazepine prescribing in General Practice in France: a data-based study
Rosman, S., Le Vaillant, M., & Pelletier-Fleury, N. (2011) · BMC Family Practice · doi:10.1186/1471-2296-12-28 · Cited by 43
The efficacy of benzodiazepines as acute anxiolytics in children: A meta-analysis
Kuang, H., Johnson, J. A., Mulqueen, J. M., & Bloch, M. H. (2017) · Depression and Anxiety · doi:10.1002/da.22643 · Cited by 43
Psychopharmacology in Pregnancy and Breastfeeding
Payne, J. L. (2019) · Medical Clinics of North America · doi:10.1016/j.mcna.2019.02.009 · Cited by 42
Meprobamate: A Study of Irrational Drug Use
Greenblatt, D. J., & Shader, R. I. (1971) · American Journal of Psychiatry · doi:10.1176/ajp.127.10.1297 · Cited by 40
A retrospective study of 34 catatonic patients: analysis of clinical care and treatment
Tuerlings, J. H. A. M., van Waarde, J. A., & Verwey, B. (2010) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2010.08.007 · Cited by 40
Optimizing ECT Technique in Treating Catatonia
Fink, M., Kellner, C. H., & McCall, W. V. (2016) · The Journal of ECT · doi:10.1097/yct.0000000000000345 · Cited by 40
Hovens, J. E. J. M., Dries, P. J. T., Melman, C. T. M., Wapenaar, R., & LOONEN, A. J. M. (2005) · Journal of Psychopharmacology · doi:10.1177/0269881105048897 · Cited by 39
Boukrina, O. V., & Barrett, A. M. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.09.024 · Cited by 39
Sheikh, J. I., & Swales, P. J. (1999) · The International Journal of Psychiatry in Medicine · doi:10.2190/kqej-mqjr-vk3d-f3hv · Cited by 35
Moylan, S., Staples, J., Ward, S. A., Rogerson, J., Stein, D. J., & Berk, M. (2011) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31822d0012 · Cited by 34
Benzodiazepines: A Valuable Tool in the Management of Cardiovascular Conditions
Balon, R., Rafanelli, C., & Sonino, N. (2018) · Psychotherapy and Psychosomatics · doi:10.1159/000493015 · Cited by 34
The role of alprazolam for the treatment of panic disorder in Australia
Moylan, S., Giorlando, F., Nordfjærn, T., & Berk, M. (2012) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867411432074 · Cited by 33
Cleft palate, mortality and morbidity in infants of substance abusing mothers
THOMAS, D. (1995) · Journal of Paediatrics and Child Health · doi:10.1111/j.1440-1754.1995.tb00857.x · Cited by 32
Using Electroconvulsive Therapy for Patients With Neurological Disease
Dubovsky, S. L. (1986) · Psychiatric Services · doi:10.1176/ps.37.8.819 · Cited by 32
Self-citationRelapses and recurrences of catatonia: 30-case analysis and literature review
Lin, C.-C., Hung, Y.-Y., Tsai, M.-C., & Huang, T. (2016) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2016.01.011 · Cited by 31
Morera, A. M., Fernández-López, L., & Abreu-González, P. (2020) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2020.107994 · Cited by 31
Benzodiazepines in anxiety disorders: Reassessment of usefulness and safety
Rickels, K., & Moeller, H. J. (2019) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2018.1500031 · Cited by 30
Foitzick, M. F., Medina, N. B., Iglesias-García, L. C., & Gravielle, M. C. (2020) · Neuroscience Letters · doi:10.1016/j.neulet.2020.134801 · Cited by 30
Carter, S. G., Carberry, J. C., Grunstein, R. R., & Eckert, D. J. (2020) · CHEST Journal · doi:10.1016/j.chest.2020.02.057 · Cited by 30
Benzodiazepines for the long-term treatment of anxiety disorders?
Tibrewal, P., Looi, J. C., Allison, S. C., & Bastiampillai, T. J. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00934-x · Cited by 30
Prescription Benzodiazepine Use in Privately Insured U.S. Children and Adolescents
Bushnell, G., Crystal, S., & Olfson, M. (2019) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2019.07.006 · Cited by 29
Clinical Methodology Matters in Epidemiology: Not All Benzodiazepines Are the Same
Cosci, F., Guidi, J., Balon, R., & Fava, G. A. (2015) · Psychotherapy and Psychosomatics · doi:10.1159/000437201 · Cited by 27
Alprazolam-induced manic episode in two patients with panic disorder
Pecknold, J. C., & Fleury, D. (1986) · American Journal of Psychiatry · doi:10.1176/ajp.143.5.652 · Cited by 27
How Much Do Benzodiazepines Matter for Electroconvulsive Therapy in Patients With Major Depression?
Delamarre, L., Galvão, F., Gohier, B., Poulet, E., & Brunelin, J. (2019) · Journal of Ect · doi:10.1097/yct.0000000000000574 · Cited by 24
Sundbakk, L. M., Wood, M. E., Gran, J. M., & Nordeng, H. (2019) · PLoS ONE · doi:10.1371/journal.pone.0217830 · Cited by 24
The Additive Effects of Alcohol and Benzodiazepines on Driving
Maxwell, H., Dubois, S. J., Weaver, B., & Bédard, M. (2010) · Canadian Journal of Public Health · doi:10.1007/bf03404852 · Cited by 21
Z-drug for schizophrenia: A systematic review and meta-analysis
Kishi, T., Inada, K., Matsui, Y., & Iwata, N. (2017) · Psychiatry Research · doi:10.1016/j.psychres.2017.06.063 · Cited by 18
Eibl, J. K., Wilton, A. S., Franklyn, A. M., Kurdyak, P. A., & Marsh, D. C. (2018) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000476 · Cited by 18
Association between opioid analgesic plus benzodiazepine use and death: A case-crossover study
Yang, B. R., Oh, I., Li, J., Jeon, H., & Shin, J. (2020) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2020.110153 · Cited by 18
Benzodiazepine Treatment and Fracture Risk in Young Persons With Anxiety Disorders
Bushnell, G., Gerhard, T., Crystal, S., & Olfson, M. (2020) · PEDIATRICS · doi:10.1542/peds.2019-3478 · Cited by 18
Chronic benzodiazepine administration
Galpern, W. R., Miller, L. G., greenblatt, D. J., Szabo, G. K., Browne, T. R., & Shader, R. I. (1991) · Biochemical Pharmacology · doi:10.1016/0006-2952(91)90398-o · Cited by 17
An Empirical Review of the Impact of Triplicate Prescription of Benzodiazepines
Schwartz, H. I. (1992) · Psychiatric Services · doi:10.1176/ps.43.4.382 · Cited by 16
Heinemann, S., Brockmöller, J., Hagmayer, Y., & Himmel, W. (2019) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-019-02783-1 · Cited by 15
Cordovilla‐Guardia, S., Molina, T. B., Franco‐Antonio, C., Santano‐Mogena, E., & Vilar‐López, R. (2020) · PLoS ONE · doi:10.1371/journal.pone.0227696 · Cited by 14
Fatal Toxicity Indices for Medicine-Related Deaths in New Zealand, 2008–2013
Fountain, J. S., Tomlin, A. M., Reith, D. M., & Tilyard, M. (2019) · Drug Safety · doi:10.1007/s40264-019-00885-4 · Cited by 12
Benzodiazepines’ Role in Managing Gastrointestinal Disorders
Balon, R., Sonino, N., & Rafanelli, C. (2021) · Psychotherapy and Psychosomatics · doi:10.1159/000510686 · Cited by 10
Auriacombe, M., Grabot, D., Lincheneau, P. M., Zeiter, D., & Tignol, J.-P. (1995) · European Psychiatry · doi:10.1016/0924-9338(96)80313-0 · Cited by 8
Johansen, M. E., & Niforatos, J. D. (2019) · Journal of General Internal Medicine · doi:10.1007/s11606-019-05042-2 · Cited by 7
Clarifying the Relationship Between Benzodiazepines and Dementia
Espinoza, R. T. (2020) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2019.12.006 · Cited by 6
Antidepressants versus placebo for generalised anxiety disorder (GAD)
Guaiana, G., Barbui, C., & Abouhassan, R. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012942 · Cited by 4
Consequences of the 1989 New York State Triplicate Benzodiazepine Prescription Regulations
WEINTRAUB, M. I., Singh, S., Byrne, L., Maharaj, K., & Guttmacher, L. B. (1993) · PsycEXTRA Dataset · doi:10.1037/e496022006-009 · Cited by 4
Are Adverse Reproductive Outcomes Associated With the Illness or Its Treatment (or Both)?
Wisner, K. L., & Yonkers, K. A. (2019) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2019.2445 · Cited by 1
Research works printed but not linked: 1
- 10.1080/15622975.2018.1500031 · DOI · Paper page
Cited by
Hirjak, D., Rogers, J. P., Wolf, R. C., Kubera, K. M., Fritze, S., Wilson, J. E., Sambataro, F., Fricchione, G. L., Meyer‐Lindenberg, A., Ungvari, G. S., et al. (2024) · Nature Reviews Disease Primers · doi:10.1038/s41572-024-00534-w · Cited by 106
Mitochondrial dysfunction and neurological disorders: A narrative review and treatment overview
Alshial, E. E., Abdulghaney, M. I., Wadan, A. S., Abdellatif, M. A., Ramadan, N. E., Suleiman, A. M., Waheed, N., Abdellatif, M., & Mohammed, H. S. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.122257 · Cited by 98
Brandt, J., Bressi, J., Lê, M.-L., Neal, D., Cadogan, C., Witt-Doerring, J., Witt-Doerring, M., & Wright, S. (2024) · eClinicalMedicine · doi:10.1016/j.eclinm.2024.102507 · Cited by 77
Huang, J., Huang, W., Yi, J., Deng, Y., Li, R., Chen, J., Shi, J., Qiu, Y., Wang, T., Chen, X., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-43150-0 · Cited by 81
Ngcobo, N. N. (2025) · Clinical Pharmacokinetics · doi:10.1007/s40262-024-01466-0 · Cited by 199
Metadata
- Authors
- Dubovsky, S. L., & Marshall, D.
- Affiliations
- University of Colorado Anschutz (US)
- University at Buffalo, State University of New York (US)
- Venue
- Psychotherapy and Psychosomatics
- Publisher
- S. Karger AG
- Published
- 2022
- Volume
- 91
- Issue
- 5
- Pages
- 307-334
- ISSN
- 0033-3190 (ISSN-L)
- 1423-0348
- OpenAlex
- W4225388848
- Cited by
- 171
- References
- 105
- Citations by year
- 2026: 40 · 2025: 44 · 2024: 41 · 2023: 38 · 2022: 8
- FWCI
- 4.78
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- karger.com/pages/terms-and-conditions (vor)
- karger.com/pages/terms-and-conditions (tdm)
- Locations
- Psychotherapy and Psychosomatics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Physical Sciences › Chemistry › Organic Chemistry › Synthesis and pharmacology of benzodiazepine derivatives
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Keywords
- benzodiazepines, Z-drugs, anxiety disorders, insomnia, alcohol withdrawal, catatonia, anxious depression, mania, sedation, tolerance (pharmacology and immunology), cognitive impairment, dementia risk, benzodiazepine misuse, benzodiazepine overdose, benzodiazepine receptor, mechanism of action
- MeSH terms
- Alcoholism, Anxiety, Benzodiazepines, Humans, Substance Withdrawal Syndrome, Substance-Related Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.